394 related articles for article (PubMed ID: 27184294)
1. A novel "complement-metabolism-inflammasome axis" as a key regulator of immune cell effector function.
Arbore G; Kemper C
Eur J Immunol; 2016 Jul; 46(7):1563-73. PubMed ID: 27184294
[TBL] [Abstract][Full Text] [Related]
2. The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging.
Meyers AK; Zhu X
Cells; 2020 Jul; 9(8):. PubMed ID: 32751530
[TBL] [Abstract][Full Text] [Related]
3. Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization.
Malsy J; Alvarado AC; Lamontagne JO; Strittmatter K; Marneros AG
Elife; 2020 Dec; 9():. PubMed ID: 33305736
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release.
Laudisi F; Spreafico R; Evrard M; Hughes TR; Mandriani B; Kandasamy M; Morgan BP; Sivasankar B; Mortellaro A
J Immunol; 2013 Aug; 191(3):1006-10. PubMed ID: 23817414
[TBL] [Abstract][Full Text] [Related]
5. External Liver-Derived Complement and Intrinsic Present in Hematopoietic Stem/Progenitor Cells Complosome Modulate Cell Metabolism and Response to Stress.
Thapa A; Ratajczak J; Kucia M; Ratajczak MZ
Stem Cell Rev Rep; 2023 Jul; 19(5):1177-1184. PubMed ID: 36976465
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
Niyonzima N; Bakke SS; Gregersen I; Holm S; Sandanger Ø; Orrem HL; Sporsheim B; Ryan L; Kong XY; Dahl TB; Skjelland M; Sørensen KK; Rokstad AM; Yndestad A; Latz E; Gullestad L; Andersen GØ; Damås JK; Aukrust P; Mollnes TE; Halvorsen B; Espevik T
EBioMedicine; 2020 Oct; 60():102985. PubMed ID: 32927275
[TBL] [Abstract][Full Text] [Related]
7. Internalization of the Membrane Attack Complex Triggers NLRP3 Inflammasome Activation and IL-1β Secretion in Human Macrophages.
Diaz-Del-Olmo I; Worboys J; Martin-Sanchez F; Gritsenko A; Ambrose AR; Tannahill GM; Nichols EM; Lopez-Castejon G; Davis DM
Front Immunol; 2021; 12():720655. PubMed ID: 34650553
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.
Feng X; Luo D; Wei G; Zhan F; Hua F; Xu G
Int Immunopharmacol; 2021 Nov; 100():108105. PubMed ID: 34481143
[TBL] [Abstract][Full Text] [Related]
9. All-Trans Retinoic Acid Enhances both the Signaling for Priming and the Glycolysis for Activation of NLRP3 Inflammasome in Human Macrophage.
Alatshan A; Kovács GE; Aladdin A; Czimmerer Z; Tar K; Benkő S
Cells; 2020 Jul; 9(7):. PubMed ID: 32630207
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
[TBL] [Abstract][Full Text] [Related]
11. Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways.
Rahman MM; McFadden G
J Virol; 2011 Dec; 85(23):12505-17. PubMed ID: 21957307
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway.
Duez H; Pourcet B
Front Endocrinol (Lausanne); 2021; 12():630536. PubMed ID: 33716981
[TBL] [Abstract][Full Text] [Related]
13. ATP-Nlrp3 Inflammasome-Complement Cascade Axis in Sterile Brain Inflammation in Psychiatric Patients and its Impact on Stem Cell Trafficking.
Ratajczak MZ; Mack A; Bujko K; Domingues A; Pedziwiatr D; Kucia M; Ratajczak J; Ulrich H; Kucharska-Mazur J; Samochowiec J
Stem Cell Rev Rep; 2019 Aug; 15(4):497-505. PubMed ID: 31020518
[TBL] [Abstract][Full Text] [Related]
14. Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative Damage.
Brandstetter C; Holz FG; Krohne TU
J Biol Chem; 2015 Dec; 290(52):31189-98. PubMed ID: 26565031
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
[TBL] [Abstract][Full Text] [Related]
16. The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.
Yu S; Wang D; Huang L; Zhang Y; Luo R; Adah D; Tang Y; Zhao K; Lu B
J Biol Chem; 2019 May; 294(21):8384-8394. PubMed ID: 30971430
[TBL] [Abstract][Full Text] [Related]
17. POP1 inhibits MSU-induced inflammasome activation and ameliorates gout.
de Almeida L; Devi S; Indramohan M; Huang QQ; Ratsimandresy RA; Pope RM; Dorfleutner A; Stehlik C
Front Immunol; 2022; 13():912069. PubMed ID: 36225929
[TBL] [Abstract][Full Text] [Related]
18. The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity.
Li XX; Lee JD; Kemper C; Woodruff TM
J Immunol; 2019 Jun; 202(12):3339-3348. PubMed ID: 31160390
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 Inflammasome and Its Critical Role in Gynecological Disorders and Obstetrical Complications.
Fang X; Wang Y; Zhang Y; Li Y; Kwak-Kim J; Wu L
Front Immunol; 2020; 11():555826. PubMed ID: 33584639
[TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
